Arteris, Inc. SEC Filings

Arteris, Inc. (AIP) submitted a Form 144 notifying the proposed sale of 2,057 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $18,163.31 and an approximate sale date of 09/04/2025. The shares were acquired as Restricted Stock Units on 09/01/2025. The filing also discloses multiple sales by the same account and related parties over the prior three months, including large 10b5-1 planned sales on 08/05/2025 and other dates. The filer attests there is no undisclosed material adverse information.

Arteris, Inc. (AIP) insider Moll Laurent R, Chief Operating Officer and director, reported stock dispositions on 09/02/2025. The Form 4 shows three sales executed at $8.9417 per share: 868 shares, 17,264 shares and 24,560 shares. The filings show remaining beneficial ownership after each sale of 441,203; 423,939; and 399,379 shares, respectively. The Form states the shares were sold to satisfy the reporting person’s tax liability arising from the release of restricted stock units.

The Form 4 was signed by an attorney-in-fact on 09/03/2025. The disclosure documents the officer’s routine tax-related stock withholding and satisfies Section 16 reporting obligations.

Janac K. Charles, who serves as President and CEO, a director and a >10% owner of Arteris, Inc. (AIP), reported a sale of 1,246 shares of common stock on 09/02/2025 at a price of $8.9417 per share to satisfy the reporting person’s tax liability arising from the release of restricted stock units. After the transaction, the filing shows 188,539 shares beneficially owned directly by the reporting person, plus 9,839,071 shares indirectly held by Bayview Legacy, LLC and 56,252 shares indirectly held by the Charles and Lydia Janac Trust. The filer is the manager of Bayview Legacy, LLC and trustee of the trust. The Form 4 was signed by an attorney-in-fact on 09/03/2025.

Arteris, Inc. (AIP) Form 4: Nicholas B. Hawkins, Vice President and Chief Financial Officer, reported a sale of 438 shares of Arteris common stock on 09/02/2025 at a price of $8.9417 per share. The filing states the shares were sold to satisfy the reporting person’s tax liability arising from the release of restricted stock units. After the transaction Hawkins beneficially owned 107,558 shares, held directly. The form was signed by an attorney-in-fact on behalf of Hawkins on 09/03/2025.

Arteris, Inc. (AIP) reporting person Paul L. Alpern, VP and General Counsel, disclosed a routine sale of common stock on 09/02/2025. The Form 4 shows 258 shares sold at $8.9417 per share under transaction code S(1), with the filing explaining the shares were sold to satisfy the reporting person’s tax liability arising from the release of restricted stock units. Following the sale, Mr. Alpern beneficially owns 76,289 shares directly. The form is signed by Paul Alpern on 09/03/2025 and indicates a single reporting person filing.

Arteris, Inc. (AIP) Form 4 filing: 10% owner Bayview Legacy, LLC, managed by CEO K. Charles Janac, reported the sale of 50,000 common shares on 08/05/2025. The trade, executed under a Rule 10b5-1 plan adopted 03/05/2025, was coded “S” (open-market sale). Weighted-average price: $13.1199, with individual transactions between $12.35 and $14.20.

Following the sale, Bayview Legacy’s indirect beneficial ownership stands at 9,839,071 shares. No derivative transactions were reported. Janac has filed a separate Form 4 reflecting the same activity due to his control of the LLC.

The disposition represents roughly 0.5% of Bayview Legacy’s post-transaction holdings, leaving the insider with a substantial stake and signaling limited portfolio rebalancing rather than a material exit.